Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Core EBITDA Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 67.63-48.67-10.49286.35-37.36

What is the latest Core EBITDA Growth ratio of NGL FINECHEM ?

The latest Core EBITDA Growth ratio of NGL FINECHEM is 67.63 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202467.63
Mar2023-48.67
Mar2022-10.49
Mar2021286.35
Mar2020-37.36

How is Core EBITDA Growth of NGL FINECHEM Trending?

Years Core EBITDA Growth % Change
Mar2024 67.63
Positive
Mar2023 -48.67
Negative
Mar2022 -10.49
Negative
Mar2021 286.35
Positive
Mar2020 -37.36 -

Other Financial Ratios of NGL FINECHEM


Compare Core EBITDA Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹812.0 Cr -4.6% 32.3% -47.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,872.0 Cr -2.1% 1.7% 6.3% Stock Analytics
DIVIS LABORATORIES ₹177,609.0 Cr -1.5% 1.5% 46.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,277.0 Cr 2.5% 11.2% 15.3% Stock Analytics
CIPLA ₹119,184.0 Cr -1% -1.7% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,116.0 Cr -0.1% -5% -5.6% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-4.6%

32.3%

-47.5%

SENSEX

-0.1%

1%

1.8%


You may also like the below Video Courses